TheroZap™

TherOZap™  Next Generation Thermal Therapy Insect Bite Device

OVERVIEW

Therma Bright Inc. continues its development of the revolutionary new TherOZap™ device, designed not only for pain relief for insect bites and stings, but to neutralize the viruses that are transferred to the dermis and epidermis layers of the skin. Global Wellness Products will act the primary distributor and sales and marketing company for TherOZap™ when it is brought to market at some point later in 2025.

TherOZap™ is the next generation in pain management relief using thermal therapy for insect bites and stings. The TherOZap™ thermal relief therapy aims to reduce the inflammatory response, relieving the symptoms of pain, itch and inflammation associated with over 20,000 different insect bites and stings.

TherOZap™  Research And Development

ZIKA Research:  Currently, Therma Bright has been working with engineers and designers to complete testing for effectiveness against fighting and killing the Zika virus and other mosquito borne diseases.  Researchers have suggested that the Zika virus, West Nile virus, Dengue Fever and other mosquito borne disease stay in the area of the bite and/or sting for a limited period of time in the dermis and epidermis of the skin, before entering the blood stream and carrying the virus throughout the body. Our researchers believe that if the TherOZap™ thermal-based device is placed on the bite immediately following a bite/sting, the thermal heat can kill the virus prior to it spreading throughout the body. Once approved testing is complete, Therma Bright will seek to secure all regulatory approvals and certifications prior to beginning outsource manufacturing and sales distribution channels of the TherOZap™.